Lung parenchyma remodeling in acute respiratory distress syndrome

Minerva Anestesiologica

Volumn 75, Issue 12, 2009, Pages 730-740

  Rocco, P R M ^a   Dos Santos, C ^b   Pelosi, P ^c  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

Adrenal cortex hormones; Extracellular matrix; Respiration, artificial; Stem cells

Indexed keywords

COLLAGEN; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ELASTIN; FIBRONECTIN; GAMMA INTERFERON; GLYCOSAMINOGLYCAN; LAMININ; METHYLPREDNISOLONE; PROSTAGLANDIN E2; PROTEOGLYCAN; TRANSFORMING GROWTH FACTOR BETA;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; ARTIFICIAL VENTILATION; AUTOPSY; BIOMECHANICS; CLINICAL TRIAL; DISEASE COURSE; DRUG MEGADOSE; ENVIRONMENTAL FACTOR; EPITHELIUM; EXTRACELLULAR MATRIX; HEREDITY; HUMAN; INFLAMMATION; LOW DRUG DOSE; LUNG FIBROSIS; LUNG PARENCHYMA; MACROMOLECULE; MORBIDITY; MORTALITY; NEUROMUSCULAR DISEASE; PATHOPHYSIOLOGY; REVIEW; STEM CELL TRANSPLANTATION; STEROID THERAPY;

AIRWAY REMODELING; HUMANS; LUNG; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 74049135496     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (78)

1. Phua J, Badia JR, Adhikari NK, Friedrich JO, Fowler RA, Singh JM et al. Has mortality from acute respiratory distress syndrome decreased over time?: A systematic review. Am J Respir Crit Care Med 2009;179:220-7.
2. Marshall RP, Bellingan G, Webb S, Puddicombe A, Goldsack N, McAnulty RJ et al. Fibroproliferation occurs early in the acute respiratory distress syndrome and impacts on outcome. Am J Respir Crit Care Med 2000;162:1783-8.
3. Rocco PRM, Negri EM, Kurtz PM, Vasconcellos FP, Silva GH, Capelozzi VL et al. Lung tissue mechanics and extracellular matrix in acute lung injury. Am J Respir Crit Care Med 2001;164:1067-71.
4. Papazian L, Doddoli C, Chetaille B, Gernez Y, Thirion X, Roch A et al. A contributive result of open-lung biopsy improves survival in acute respiratory distress syndrome patients. Crit Care Med 2007;35: 755-62.
5. Meduri GU. Late adult respiratory distress syndrome. New Horiz 1993;1:563-77.
6. Martin C, Papazian L, Payan MJ, Saux P, Gouin F. Pulmonary fibrosis correlates with outcome in adult respiratory distress syndrome. A study in mechanically ventilated patients. Chest 1995;107:196-200.
7. Pelosi P, Rocco PR. Effects of mechanical ventilation on the extracellular matrix. Intensive Care Med 2008;34:631-9.
8. Santos FB, Nagato LKS, Boechem NM, Negri EM, Guimarães A, Capelozzi VL et al. Time course of lung parenchyma remodeling in pulmonary and extrapulmonary acute lung injury. J Appl Physiol 2006;100:98-106.
9. Rocco PRM, Souza AB, Faffe DS, Passaro CP, Santos FB, Negri EM et al. Effect of corticosteroid on lung parenchyma remodeling at an early phase of acute lung injury. Am J Respir Crit Care Med 2003;168:677-84.
10. Pelosi P, Rocco PR, Negrini D, Passi A. The extracellular matrix of the lung and its role in edema formation. An Acad Bras Cienc 2007;79:285-97.
11. Negri EM, Montes GS, Saldiva PH, Cappelozzi VL. Architectural remodelling in acute and chronic interstitial lung disease: fibrosis or fibroelastosis? Histopathology 2000;37:393-401.
12. Souza-Fernandes AB, Pelosi P, Rocco PR. Bench-to-bedside review: the role of glycosaminoglycans in respiratory disease. Crit Care 2006;10:237.
13. Bellingan GJ. The pulmonary physician in critical care: The pathogenesis of ALI/ARDS. Thorax 2002;57:540-6.
14. Geiser T. Mechanisms of alveolar epithelial repair in acute lung injury - a translational approach. Swiss Med Wkly 2003;133:586-90.
15. Dos Santos CC. Advances in mechanisms of repair and remodelling in acute lung injury. Intensive Care Med 2008;34:619-30.
16. Silva PL, Garcia CS, Maronas PA, Cagido VR, Negri EM, Damaceno-Rodrigues NR et al. Early short-term versus prolonged low-dose methylprednisolone therapy in acute lung injury. Eur Respir J 2009;33: 634-45.
17. Weinberger SE, Kelman JA, Elson NA, Young RC Jr, Reynolds HY, Fulmer JD et al. Bronchoalveolar lavage in interstitial lung disease. Ann Intern Med 1978;89:459-66.
18. Ranieri VM, Suter PM, Tortorella C, De Tullio R, Dayer JM, Brienza A et al. Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial. JAMA 1999;282:54-61.
19. Henke C, Marineili W, Jessurun J, Fox J, Harms D, Peterson M et al. Macrophage production of basic fibroblast growth factor in the fibroproliferative disorder of alveolar fibrosis after lung injury. Am J Pathol 1993;143:1189-99.
20. Krein PM, Sabatini PJ, Tinmouth W, Green FH, Winston BW. Localization of insulin-like growth factor-I in lung tissues of patients with fibroproliferative acute respiratory distress syndrome. Am J Respir Crit Care Med 2003;167:83-90.
21. Madtes DK, Rubenfeld G, Klima LD, Milberg JA, Steinberg KP, Martin TR et al. Elevated transforming growth factoralpha levels in bronchoalveolar lavage fluid of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 1998;158:424-30.
22. Menezes SL, Bozza PT, Neto HC, Laranjeira AP, Negri EM, Capelozzi VL et al. Pulmonary and extrapulmonary acute lung injury: inflammatory and ultrastructural analyses. J Appl Physiol 2005;98:1777-83.
23. Leite-Junior JH, Garcia CS, Souza-Fernandes AB, Silva PL, Ornellas DS, Larangeira AP et al. Methylprednisolone improves lung mechanics and reduces the inflammatory response in pulmonary but not in extrapulmonary mild acute lung injury in mice.Crit Care Med 2008;36:2621-8.
24. Kuwano K, Hagimoto N, Hara N. Molecular mechanisms of pulmonary fibrosis and current treatment. Curr Mol Med 2001;1:551-73.
25. Sugahara K, Tokumine J, Teruya K, Oshiro T. Alveolar epithelial cells: differentiation and lung injury. Respirology 2006;11:S28-S31.
26. Selman M, King TE, Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 2001;134:136-51.
27. Dhainaut JF, Charpentier J, Chiche JD. Transforming growth factor-beta: a mediator of cell regulation in acute respiratory distress syndrome. Crit Care Med 2003;31:S258-64.
28. Pittet JF, Griffiths MJ, Geiser T, Kaminski N, Dalton SL, Huang X et al. TGF-beta is a critical mediator of acute lung injury. J Clin Invest 2001;107:1537-44.
29. Nishioka A, Ogawa Y, Mima T, Jin YJ, Sonobe H, Kariya S et al. Histopathologic amelioration of fibroproliferative change in rat irradiated lung using soluble transforming growth factor-beta (TGF-beta) receptor mediated by adenoviral vector. Int J Radiat Oncol Biol Phys 2004;58:1235-41.
30. Munger JS, Huang X, Kawakatsu H, Griffiths MJ, Dalton SL, Wu J et al. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 1999;96:319-28.
31. Vancheri C, Sortino MA, Tomaselli V, Mastruzzo C, Condorelli F, Bellistri G et al. Different expression of TNF-alpha receptors and prostaglandin E(2) production in normal and fibrotic lung fibroblasts: potential implications for the evolution of the inflammatory process. Am J Respir Cell Mol Biol 2000;22:628-34.
32. Hodges RJ, Jenkins RG, Wheeler-Jones CP, Copeman DM, Bottoms SE, Bellingan GJ et al. Severity of lung injury in cyclooxygenase-2-deficient mice is dependent on reduced prostaglandin E(2) production. Am J Pathol 2004;165:1663-76.
33. Savla U, Appel HJ, Sporn PH, Waters CM. Prostaglandin E(2) regulates wound closure in airway epithelium. Am J Physiol Lung Cell Mol Physiol 2001;280:L421-31.
34. White ES, Atrasz RG, Dickie EG, Aronoff DM, Stambolic V, Mak TW et al. Prostaglandin E(2) inhibits fibroblast migration by E-prostanoid 2 receptor-mediated increase in PTEN activity. Am J Respir Cell Mol Biol 2005;32:135-141.
35. Zhu YK, Liu XD, Skold MC, Umino T, Wang H, Romberger DJ et al. Cytokine inhibition of fibroblast-induced gel contraction is mediated by PGE(2) and NO acting through separate parallel pathways. Am J Respir Cell Mol Biol 2001;25:245-53.
36. Choung J, Taylor L, Thomas K, Zhou X, Kagan H, Yang X et al. Role of EP2 receptors and cAMP in prostaglandin E2 regulated expression of type I collagen alpha1, lysyl oxidase, and cyclooxygenase-1 genes in human embryo lung fibroblasts. J Cell Biochem 1998;71:254-63.
37. Skold CM, Liu XD, Zhu YK, Umino T, Takigawa K, Ohkuni Y et al. Glucocorticoids augment fibroblast-mediated contraction of collagen gels by inhibition of endogenous PGE production. Proc Assoc Am Physicians 1999;111:249-58.
38. Thomas PE, Peters-Golden M, White ES, Thannickal VJ, Moore BB. PGE(2) inhibition of TGF-beta1-induced myofibroblast differentiation is Smad-independent but involves cell shape and adhesion-dependent signaling. Am J Physiol Lung Cell Mol Physiol 2007;293:L417-28.
39. Gurujeyalakshmi G, Giri SN. Molecular mechanisms of antifibrotic effect of interferon gamma in bleomycin-mouse model of lung fibrosis: down-regulation of TGF-betaand pro-collagen I and III gene expression. Exp Lung Res 1995;21:791-808.
40. Venkatesan N, Roughley PJ, Ludwig MS. Proteoglycan expression in bleomycin lung fibroblasts: role of transforming growth factor-beta(1) and interferon-gamma. Am J Physiol Lung Cell Mol Physiol 2002;283:L806-14.
41. Maquart FX, Pasco S, Ramont L, Hornebeck W, Monboisse JC. An introduction to matrikines: extracellular matrix-derived peptides which regulate cell activity. Implication in tumor invasion. Crit Rev Oncol Hematol 2004;49:199-202.
42. Horowitz JC, Cui Z, Moore TA, Meier TR, Reddy RC, Toews GB et al. Constitutive activation of prosurvival signaling in alveolar mesenchymal cells isolated from patients with nonresolving acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 2006;290:L415-25.
43. Kuwano K. Epithelial cell apoptosis and lung remodeling. Cell Mol Immunol 2007;4:419-29.
44. Albertine KH, Soulier MF, Wang Z, Ishizaka A, Hashimoto S, Zimmerman GA et al. Fas and fas ligand are up-regulated in pulmonary edema fluid and lung tissue of patients with acute lung injury and the acute respiratory distress syndrome. Am J Pathol 2002;161:1783-96.
45. Kawasaki M, Kuwano K, Hagimoto N, Matsuba T, Kunitake R, Tanaka T et al. Protection from lethal apoptosis in lipopolysaccharide-induced acute lung injury in mice by a caspase inhibitor. Am J Pathol 2002;157:597-603.
46. Kuwano K, Kunitake R, Maeyama T, Hagimoto N, Kawasaki M, Matsuba T et al. Attenuation of bleomycin-induced pneumopathy in mice by a caspase inhibitor. Am J Physiol Lung Cell Mol Physiol 2001;280:L316-25.
47. Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan B et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 2005;436:112-6.
48. Hagimoto N, Kuwano K, Inoshima I, Yoshimi M, Nakamura N, Fujita M et al. TGF-beta 1 as an enhancer of Fas-mediated apoptosis of lung epithelial cells. J Immunol 2002;168:6470-8.
49. Imai Y, Parodo J, Kajikawa O, de Perrot M, Fischer S, Edwards V et al. Injurious mechanical ventilation and end-organ epithelial cell apoptosis and organ dysfunction in an experimental model of acute respiratory distress syndrome. JAMA 2003;289:2104-12.
50. Le A, Damico R, Damarla M, Boueiz A, Pae HH, Skirball J et al. Alveolar cell apoptosis is dependent on p38 MAP kinasemediated activation of xanthine oxidoreductase in ventilator-induced lung injury. J Appl Physiol 2008;105:1282-90.
51. Kim KK, Kugler MC, Wolters PJ, Robillard L, Galvez MG, Brumwell AN et al. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci USA 2006; 103:13180-5.
52. Deheinzelin D, Jatene FB, Saldiva PH, Brentani RR. Upregulation of collagen messenger RNA expression occurs immediately after lung damage. Chest 1997;112:1184-8.
53. Garcia CS, Rocco PR, Fachinetti LD, Lassance RM, Caruso P, Deheinzelin D et al. What increases type III procollagen mRNA levels in lung tissue: stress induced by changes in force or amplitude? Respir Physiol Neurobiol 2004;144:59-70.
54. Farias LL, Faffe DS, Xisto DG, Santana MC, Lassance R, Prota LF et al. Positive end-expiratory pressure prevents lung mechanical stress caused by recruitment/derecruitment. J Appl Physiol 2005;98:53-61.
55. Berg JT, Fu Z, Breen EC, Tran HC, Mathieu-Costello O, West JB. High lung inflation increases mRNA levels of ECM components and growth factors in lung parenchyma. J Appl Physiol 1997;83:120-8.
56. Parker JC, Breen EC, West JB. High vascular and airway pressures increase interstitial protein mRNA expression in isolated rat lungs. J Appl Physiol 1997;83:1697-705.
57. Riva DR, Oliveira MB, Rzezinski AF, Rangel G, Capelozzi VL, Zin WA et al. Recruitment maneuver in pulmonary and extrapulmonary experimental acute lung injury. Crit Care Med 2008;36:1900-8.
58. Steimback PW, Oliveira GP, Rzezinski AF, Silva PL, Garcia CS, Rangel G et al. Effects of frequency and inspiratory plateau pressure during recruitment manoeuvres on lung and distal organs in acute lung injury. Intensive Care Med 2009 [Epub ahead of print].
59. Al Jamal R, Ludwig MS. Changes in proteoglycans and lung tissue mechanics during excessive mechanical ventilation in rats. Am J Physiol Lung Cell Mol Physiol 2001;281:L1078-87.
60. Moriondo A, Pelosi P, Passi A, Viola M, Marcozzi C, Severgnini P et al. Proteoglycans fragmentation and respiratory mechanics in mechanically ventilated healthy rats. J Appl Physiol 2007;103:747-56.
61. Johnson Z, Proudfoot AE, Handel TM. Interaction of chemokines and glycosaminoglycans: a new twist in the regulation of chemokine function with opportunities for therapeutic intervention. Cytokine Growth Factor Rev 2005;16:625-36.
62. Schaefer L, Babelova A, Kiss E, Hausser HJ, Baliova M, Krzyzankova M et al. The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. J Clin Invest 2005;115:2223-33.
63. D'Angelo E, Pecchiari M, Gentile G. Dependence of lung injury on surface tension during low-volume ventilation in normal open-chest rabbits. J Appl Physiol 2007;102:174-82.
64. Fernandes AB, Zin WA, Rocco PR. Corticosteroids in acute respiratory distress syndrome. Braz J Med Biol Res 2005;38:147-59.
65. Meduri GU, Marik PE, Chrousos GP, Pastores SM, Arlt W, Beishuizen A et al. Steroid treatment in ARDS: a critical appraisal of the ARDS network trial and the recent literature. Intensive Care Med 2008;34:61-9.
66. Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 2006;354:1671-84.
67. Annane D, Sebille V, Bellissant E, Ger-Inf-05 Study Group. Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome. Crit Care Med 2006;34:22-30.
68. Meduri GU, Golden E, Freire AX, Taylor E, Zaman M, Carson SJ et al. Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest 2007;131:954-63.
69. Rocco PR, Pelosi P. Pulmonary and extrapulmonary acute respiratory distress syndrome: myth or reality? Curr Opin Crit Care 2008;14:50-5.
70. Marshall RP, McAnulty RJ, Laurent GJ. Angiotensin II is mitogenic for human lung fibroblasts via activation of the type 1 receptor. Am J Respir Crit Care Med 2000;161:1999-2004.
71. Ward WF, Molteni A, Ts'ao CH, Hinz JM. Captopril reduces collagen and mast cell accumulation in irradiated rat lung. Int J Radiat Oncol Biol Phys 1990;19:1405-9.
72. Marshall RP, Gohlke P, Chambers RC, Howell DC, Bottoms SE, Unger T et al. Angiotensin II and the fibroproliferative response to acute lung injury. Am J Physiol Lung Cell Mol Physiol 2004;286:L156-64.
73. Krause DS. Bone marrow-derived cells and stem cells in lung repair. Proc Am Thorac Soc 2008;5:323-7.
74. Yamada M, Kubo H, Kobayashi S, Ishizawa K, Numasaki M, Ueda S et al. Bone marrow-derived progenitor cells are important for lung repair after lipopolysaccharide-induced lung injury. J Immunol 2004;172:1266-72.
75. Gupta N, Su X, Popov B, Lee JW, Serikov V, Matthay MA. Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxininduced acute lung injury in mice. J Immunol 2007;179:1855-63.
76. Xu J, Woods CR, Mora AL, Joodi R, Brigham KL, Iyer S et al. Prevention of endotoxin-induced systemic response by bone marrow-derived mesenchymal stem cells in mice. Am J Physiol Lung Cell Mol Physiol 2007;293:L131-41.
77. Mei SH, McCarter SD, Deng Y, Parker CH, Liles WC, Stewart DJ. Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1. PLoS Med 2007;4:e269.
78. Araujo I, Abreu S, Cruz F, Fujisaki L, Maron-Gutierrez T, Ornellas F et al. Bone marrow mononuclear cell therapy led to a better morpho-functional response in extrapulmonary compared to pulmonary acute lung injury. Am J Respir Crit Care Med 2009;179:A2501.